SCHEMBL31728863

SCHEMBL31728863

Nc1ncnc2c(-c3cccc(Cl)c3Cl)cc(B(O)O)cc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DGAT1 O75907 1/20 0.39
▸ NUDT1 P36639 6/20 0.38
▸ CYP2D6 P10635 1/20 0.35
▸ MAOA P21397 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ ADRA1A P35348 1/20 0.35
▸ SCN4A P35499 1/20 0.35
▸ BLM P54132 1/20 0.35
▸ PMP22 Q01453 1/20 0.35
▸ PDE3A Q14432 1/20 0.35
▸ SCN5A Q14524 1/20 0.35
▸ SCN9A Q15858 1/20 0.35
▸ SCN2A Q99250 1/20 0.35
▸ SCN3A Q9NY46 1/20 0.35
▸ SCN10A Q9Y5Y9 1/20 0.35
▸ PLG P00747 1/20 0.34
▸ F12 P00748 1/20 0.34
▸ F11 P03951 1/20 0.34
▸ KLKB1 P03952 1/20 0.34
▸ PRSS1 P07477 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31728633 0.81 MAP4K4 (0.41) DGAT1NUDT1CYP2D6MAOAMAPK1
SCHEMBL31727873 0.81 SMN1; SMN2 (0.40) DGAT1NUDT1CYP2D6MAOAMAPK1
SCHEMBL31727998 0.74 MAP4K4 (0.49) DGAT1MAP4K4PTPN11
SCHEMBL31729125 0.73 DGAT1 (0.38) DGAT1NUDT1CYP2D6MAOAMAPK1
SCHEMBL31728080 0.72 NOTUM (0.39) DGAT1NUDT1
SCHEMBL31729239 0.72 CNR2 (0.53) DGAT1PTPN11
SCHEMBL31728894 0.72 PTPN11 (0.41) DGAT1NUDT1PTPN11
SCHEMBL31728779 0.72 NOTUM (0.43) DGAT1NUDT1
SCHEMBL31728623 0.68 SMN1; SMN2 (0.39) NUDT1MAP4K4PDE5ADOT1LLIMK1
SCHEMBL31728545 0.68 DGAT1 (0.39) DGAT1NUDT1CYP2D6MAOAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback